Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978–2020

Improving medicines regulation can lead to better population health, but how this process works in low- and middle-income countries remains underexplored. Tanzania's pharmaceutical sector is often cited as a successful example of a well-functioning regulatory system in a developing country, attributed to the work of the Tanzania Food and Drugs Authority (TFDA), now the Tanzania Medicines and Medical Devices Authority (TMDA). This raises the question: how was this regulatory capacity developed, and what lessons can other countries learn from Tanzania's experience? This paper analyzes changes in Tanzania's pharmaceutical regulation over three periods of significant sectoral reform. A desk review was conducted of Tanzania's policies, laws, regulations, guidelines, procedures, and institutional reports. The study reveals that Tanzania's regulatory capacity improved significantly through targeted reforms that addressed challenges in key regulatory areas. The three key periods examined are: 1) The separation of medicines regulation from food safety (1978-2003), 2) The expansion of regulatory domains and the establishment of a semi-autonomous regulatory agency (2003-2011), and 3) The expanded role of the Pharmacy Council to include premises regulation (2011-2020). The development of a well-functioning regulatory system in Tanzania resulted from advancements in four key areas: 1) The evolution of a legal regulatory framework, 2) Strong stakeholder engagement, 3) Continuous capacity building, and 4) Effective organizational leadership. Tanzania's regulatory system has evolved from being relatively ineffective to leading regional harmonization efforts in East Africa. This progress was not linear, requiring sustained effort, collaboration, and support from key development partners such as the Global Fund, WHO, and UNDP. Future efforts to enhance regulatory effectiveness should focus on creating adaptive systems that respond to changing needs, rather than solely prescriptive functions.

Authors

Institutions

Publication Details

Journal
PLOS Global Public Health
Published
2024-10-16
DOI
https://doi.org/10.1371/journal.pgph.0003241
Citations
4
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
4.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978–2020

Jesse B. Bump, Hiiti Sillo, Alex Nkayamba, Sunday Kisoma et al.
4 citations
PLOS Global Public Health
Pharmaceutical Economics and Policy
4.52
article

Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978–2020

Jesse B. Bump, Hiiti Sillo, Alex Nkayamba, Sunday Kisoma, Linden Morrison, Yonah Hebron Mwalwisi, Sarah Asiimwe, Adam Mitangu Fimbo, Patrick Githendu, Eliangiringa Amos Kaale, Rafiu Idris, Osondu Ogbuoji
article en
4 citations

Abstract

Improving medicines regulation can lead to better population health, but how this process works in low- and middle-income countries remains underexplored. Tanzania's pharmaceutical sector is often cited as a successful example of a well-functioning regulatory system in a developing country, attributed to the work of the Tanzania Food and Drugs Authority (TFDA), now the Tanzania Medicines and Medical Devices Authority (TMDA). This raises the question: how was this regulatory capacity developed, and what lessons can other countries learn from Tanzania's experience? This paper analyzes changes in Tanzania's pharmaceutical regulation over three periods of significant sectoral reform. A desk review was conducted of Tanzania's policies, laws, regulations, guidelines, procedures, and institutional reports. The study reveals that Tanzania's regulatory capacity improved significantly through targeted reforms that addressed challenges in key regulatory areas. The three key periods examined are: 1) The separation of medicines regulation from food safety (1978-2003), 2) The expansion of regulatory domains and the establishment of a semi-autonomous regulatory agency (2003-2011), and 3) The expanded role of the Pharmacy Council to include premises regulation (2011-2020). The development of a well-functioning regulatory system in Tanzania resulted from advancements in four key areas: 1) The evolution of a legal regulatory framework, 2) Strong stakeholder engagement, 3) Continuous capacity building, and 4) Effective organizational leadership. Tanzania's regulatory system has evolved from being relatively ineffective to leading regional harmonization efforts in East Africa. This progress was not linear, requiring sustained effort, collaboration, and support from key development partners such as the Global Fund, WHO, and UNDP. Future efforts to enhance regulatory effectiveness should focus on creating adaptive systems that respond to changing needs, rather than solely prescriptive functions.

PLOS Global Public HealthVol. 4(10)
Global Fund to Fight AIDS, Tuberculosis and Malaria (CH), Muhimbili University of Health and Allied Sciences (TZ), Duke University (US), World Health Organization (CH), Duke Institute for Health Innovation (US), Harvard Global Health Institute (US)
Global Fund to Fight AIDS, Tuberculosis and Malaria, World Health Organization, Helen Keller Foundation for Research and Education, United Nations Development Programme
Partnerships for the goals
Openalex Percentile: Top 5%
Pharmaceutical Economics and Policy
4.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.